CD7 expression and its prognostic significance in acute myeloid leukemia patients with wild-type or mutant CEBPA

被引:0
|
作者
朱名俣 [1 ]
机构
[1] Dept Hematol,1st Affil Hosp,Zhejiang Univ
关键词
D O I
暂无
中图分类号
R733.71 [急性白血病];
学科分类号
摘要
Objective To analyze the prognostic value of CD7expression in newly diagnosed acute myeloid leukemia(AML) patients,and to further explore the correlation between CD7 expression and CEBPA mutation,and to clarify the prognostic value of CD7;in AML patients with wild-type (WT) or mutant-type (MT) CEBPA.Methods The clinical data of 298 newly diagnosed non-
引用
收藏
页码:112 / 112
页数:1
相关论文
共 50 条
  • [31] Expression of SATB2 in Acute Myeloid Leukemia and Its Prognostic Significance
    Xu, Lihua
    Ye, Jingmei
    Luo, Xiaodan
    Tan, Huo
    BLOOD, 2017, 130
  • [32] Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia
    Ogata, K
    Yokose, N
    Shioi, Y
    Ishida, Y
    Tomiyama, J
    Hamaguchi, H
    Yagasaki, F
    Bessyo, M
    Sakamaki, H
    Dan, K
    Kuriya, S
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (03) : 612 - 615
  • [33] The preferential expression of CD7 and CD34 in myeloid blast crisis in chronic myeloid leukemia
    Kosugi, N
    Tojo, A
    Shinzaki, H
    Nagamura-Inoue, T
    Asano, S
    BLOOD, 2000, 95 (06) : 2188 - 2189
  • [34] Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia with Aberrant CD7 Antigen Expression
    De Novellis, Danilo
    Cacace, Fabiana
    Caprioli, Valeria
    Iannalfo, Marialuigia
    D'amico, Maria Rosaria
    De Simone, Giuseppina
    Maisto, Giovanna
    Cuccurullo, Rosanna
    Tambaro, Francesco Paolo
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 236 - 236
  • [35] CD7 receptor expression as a therapeutic target in acute myeloid Leukaemia
    Griffin, James
    Healy, Fiona
    Slupsky, Joseph
    Woolley, John
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 32 - 32
  • [36] CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
    Lin, T-C
    Hou, H-A
    Chou, W-C
    Ou, D-L
    Yu, S-L
    Tien, H-F
    Lin, L-I
    LEUKEMIA, 2011, 25 (01) : 32 - 40
  • [37] Prognostic Impact of Mutant to Wild-Type Ratio and Insertion Site in Acute Myeloid Leukemia with FLT3 Internal Tandem Duplication
    Kayser, Sabine
    Schlenk, Richard F.
    Krauter, Juergen
    Koehne, Claus-Henning
    Germing, Ulrich
    Held, Gerhard
    Horst, Heinz A.
    Ringhoffer, Mark
    von Lilienfeld-Toal, Marie
    Rummel, Mathias J.
    Goetze, Katharina
    Nachbaur, David
    Schlegelberger, Brigitte
    Goehring, Gudrun
    Salih, Helmut R.
    Martin, Hans
    Herr, Wolfgang
    Luebbert, Michael
    Salwender, Hans-Juergen
    Erdmann, Patricia
    Paschka, Peter
    Gaidzik, Verena I.
    Teleanu, Veronica
    Spaeth, Daniela
    Ganser, Arnold
    Fischer, Thomas
    Doehner, Hartmut
    Doehner, Konstanze
    BLOOD, 2012, 120 (21)
  • [38] The significance of BAALC expression and CEBPa mutations as new prognostic factors in pediatric acute myeloid leukemia with normal karyotype.
    Mizushima, Yasuhiro
    Adachi, Souichi
    Taki, Tomohiko
    Shimada, Akira
    Hayashi, Yasuhide
    Tsukimoto, Ichiro
    Yui, Masahiro
    Kamitsuji, Yuri
    Hiraumi, Yoshimi
    Matsubara, Hiroshi
    Watanabe, Motonobu
    Watanabe, Ken-Ichiro
    Nakahata, Tatsutoshi
    BLOOD, 2006, 108 (11) : 645A - 646A
  • [39] CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia
    T-C Lin
    H-A Hou
    W-C Chou
    D-L Ou
    S-L Yu
    H-F Tien
    L-I Lin
    Leukemia, 2011, 25 : 32 - 40
  • [40] Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells
    Napolitano, Roberta
    De Matteis, Serena
    Carloni, Silvia
    Bruno, Samantha
    Abbati, Giulia
    Capelli, Laura
    Ghetti, Martina
    Bochicchio, Maria Teresa
    Liverani, Chiara
    Mercatali, Laura
    Calistri, Daniele
    Cuneo, Antonio
    Menon, Krishna
    Musuraca, Gerardo
    Martinelli, Giovanni
    Simonetti, Giorgia
    ONCOLOGY REPORTS, 2020, 44 (04) : 1561 - 1573